Enteral Feeding Intolerance (EFI)
1 clinical trials · Condition
◉ Watch Enteral Feeding Intolerance (EFI)
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial (NCT02784392) | Lyric Pharmaceuticals | 2016-10-01 |
Track Enteral Feeding Intolerance (EFI) automatically
Every clearance here is in the API, with alerts when new ones post.